Tag: M.W:100-200

Electric Literature of 532-32-1, The transformation of simple hydrocarbons into more complex and valuable products via catalytic C¨CH bond functionalisation has revolutionised modern synthetic chemistry. 532-32-1, Name is Sodium benzoate, SMILES is O=C([O-])C1=CC=CC=C1.[Na+], belongs to Benzisoxazole compound. In a article, author is Ward, Michael D., introduce new discover of the category.

Guest Binding and Catalysis in the Cavity of a Cubic Coordination Cage

An M8L12 coordination cage, which is water-soluble but has a hydrophobic interior cavity, is an effective host for a wide range of small organic guests; the factors responsible for guest binding have been investigated in detail. Benzisoxazole is a competent guest and, when bound, undergoes the Kemp elimination reaction with a rate acceleration of up to 2 x 10(5) times compared to the reaction of unbound benzisoxazole; the reasons for this have been analyzed.

Electric Literature of 532-32-1, Consequently, the presence of a catalyst will permit a system to reach equilibrium more quickly, but it has no effect on the position of the equilibrium as reflected in the value of its equilibrium constant.I hope my blog about 532-32-1 is helpful to your research.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Catalysts are substances that increase the reaction rate of a chemical reaction without being consumed in the process. 98-89-5, Name is Cyclohexanecarboxylic acid, SMILES is O=C(C1CCCCC1)O, belongs to Benzisoxazole compound. In a document, author is WANG, GJ, introduce the new discover, Name: Cyclohexanecarboxylic acid.

SYNTHESIS OF HYDROPHOBICALLY AND ELECTROSTATICALLY MODIFIED POLYACRYLAMIDES AND THEIR CATALYTIC EFFECTS ON THE UNIMOLECULAR DECARBOXYLATION OF 6-NITROBENZISOXAZOLE-3-CARBOXYLATE ANION

A series of hydrophobically and electrostatically modified polyacrylamides (Copol(AM-C12)) has been synthesized by radical-initiated copolymerization of acrylamide with n-dodecylmethyldiallylammonium bromide as the hydrophobe in aqueous solution using ammonium persulfate as the initiator. The formation of hydrophobic microdomains of the copolymers was revealed by large hypsochromic shifts of the long-wavelength absorption band of the solvatochromic probe Methyl Orange, noncovalently bound to the macromolecule. It was found that the microdomains formed by these copolymers in aqueous solution are more hydrophobic than those of the cationic polysoaps poly(alkylmethyldiallylammonium halides) containing the same n-dodecyl groups as the side chains as a result of the reduced electrostatic repulsions at the periphery of the microdomains. The reduced cationic character of the copolymers Copol(AM-C12) most likely also accounts for the observation that the anionic dye Methyl Orange does not; induce microdomain formation in aqueous solution. The effect of the hydrophobically and electrostatically modified polyacrylamides on the unimolecular decarboxylation of 6-nitrobenzisoxazole-3-carboxylate anion (6-NBIC) has been investigated in aqueous solutions at pH 11.3 and 30 degrees C. It is suggested that the relatively modest catalytic effects induced by Copol(AM-C12) should be ascribed to hydrogen-bond stabilization of the initial state by NH groups in the macromolecules. The decarboxylation rates of 6-NBIC at binding sites in hydrophobic microdomains increase with increasing n-dodecyl group content in the copolymers.

The proportionality constant is the rate constant for the particular unimolecular reaction. the reaction rate is directly proportional to the concentration of the reactant. I hope my blog about 98-89-5 is helpful to your research. Name: Cyclohexanecarboxylic acid.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Chemo-enzymatic cascade processes are invaluable due to their ability to rapidly construct high-value products from available feedstock chemicals in a one-pot relay manner. In an article, author is Kwan, Shang-Yeong, once mentioned the application of 3878-55-5, Name is 4-Methoxy-4-oxobutanoic acid, molecular formula is C5H8O4, molecular weight is 132.12, MDL number is MFCD00002788, category is Benzisoxazole. Now introduce a scientific discovery about this category, Category: Benzisoxazole.

Zonisamide: Review of Recent Clinical Evidence for Treatment of Epilepsy

Zonisamide is an orally administered antiepileptic drug that was first approved for clinical use in Japan in 1989. Since then, it has been licensed in Korea for a broad spectrum of epilepsies in adults and children, and in the USA for adjunctive therapy of adults with partial seizures, and in Europe for monotherapy of adults with newly diagnosed partial seizures and adjunctive therapy of adults and adolescents and children aged 6years with partial seizures with or without secondary generalization. Zonisamide is a benzisoxazole derivative with a unique chemical structure, predictable dose-dependent pharmacokinetics, and multiple complementary mechanisms of action. Treatment with zonisamide is well tolerated and is not known to be associated with clinically significant drug-drug interactions, including with oral contraceptives or other antiepileptic drugs. There have been >2million patient-years of experience with zonisamide for treatment of epilepsy, and this drug has International League Against Epilepsy level A evidence for efficacy/effectiveness as initial monotherapy for adults with partial-onset seizures. This review presents the evidence for zonisamide across the spectrum of epilepsy, with emphasis on real-world clinical practice and special populations of patients (children, elderly patients, and women of childbearing age) who are likely to be treated in daily clinical practice.

Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 3878-55-5, Category: Benzisoxazole.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Chemistry is the experimental and theoretical study of materials on their properties at both the macroscopic and microscopic levels. 625-08-1, Name is 3-Hydroxy-3-methylbutanoic acid, molecular formula is C5H10O3. In an article, author is BRAHMESHWARI, G,once mentioned of 625-08-1, Application In Synthesis of 3-Hydroxy-3-methylbutanoic acid.

SYNTHESIS AND BIOLOGICAL-ACTIVITY OF FUSED HETEROCYCLES DERIVED FROM EMBELIN

3-Aryl-6-hydroxy-5-undecyl-1,2-benzisoxazole-4,7-diones (IIIa-e) have been obtained by the reaction of embelin (I) with aryl nitrile oxides (IIa-e). Their structures have been confirmed by converting them into the corresponding 3-aryl-5-undecylisoxazole[5,4-a] phenazin-4(6H)-ones (IVa-e) and 6-(acetyloxy)-3-aryl-5-undecyl-1,2-benzoisoxazole-4,7-diones (Va-e). These compounds are found to be active against fungi Fusarium-oxysporum and Curvularia lunata.

If you¡¯re interested in learning more about 625-08-1. The above is the message from the blog manager. Application In Synthesis of 3-Hydroxy-3-methylbutanoic acid.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Reactions catalyzed within inorganic and organic materials and at electrochemical interfaces commonly occur at high coverage and in condensed media, causing turnover rates to depend strongly on interfacial structure and composition, 619-05-6, Name is 3,4-Diaminobenzoic acid, SMILES is O=C(O)C1=CC=C(N)C(N)=C1, in an article , author is COUTINHO, DLM, once mentioned of 619-05-6, Category: Benzisoxazole.

SYNTHESIS OF HETEROCYCLES FROM 4-(2-HYDROXYBENZOYL)-1-PHENYLPYRAZOLE

4-(2-Hydroxybenzoyl)-1-phenylpyrazole (1) has been used in the synthesis of benzofuran (2), coumarin (5) and benzisoxazole (9).

Interested yet? Read on for other articles about 619-05-6, you can contact me at any time and look forward to more communication. Category: Benzisoxazole.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

701-97-3, Name is 3-Cyclohexylpropionic Acid, molecular formula is C9H16O2, Computed Properties of C9H16O2, belongs to Benzisoxazole compound, is a common compound. In a patnet, author is D’Anna, Francesca, once mentioned the new application about 701-97-3.

Kemp elimination: A probe reaction to study ionic liquids properties

The amino induced elimination of benzisoxazole into the relevant o-cyanophenolate ion (Kemp elimination) has been studied in [bmim][BF4] solution at 298 K. To have information about the interactions between reactants and ionic liquid, the reaction has been carried out at different temperatures (293-313 K). Several primary, secondary, and tertiary amines have been used to study the effect of amine structure on the reaction rate. The collected data show that the amine structure seems to have a crucial role in determining the reaction rate. Furthermore, as different cation or anion structures of an ionic liquid can significantly affect its properties, the title reaction has been performed in four different ionic liquids ([bmim][PF6], [bmim][NTf2], [bm(2)im][NTf2], and [bmpyrr][NTf2]), using pyrrolidine and piperidine as model amines. An H-donor negative solvent (MeOH and [bmim][NTf2]) effect on reaction rate was detected. Finally, a narrow range of activation parameters was calculated both for the reaction induced by different amines and for pyrrolidine and piperidine, in the presence of different ILs. This fact suggests the occurrence of an early transition state.

We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, 701-97-3. The above is the message from the blog manager. Computed Properties of C9H16O2.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

In an article, author is Okada, M, once mentioned the application of 99-06-9, Name is 3-Hydroxybenzoic acid, molecular formula is C7H6O3, molecular weight is 138.12, MDL number is MFCD00002506, category is Benzisoxazole. Now introduce a scientific discovery about this category, Category: Benzisoxazole.

Effects of zonisamide on dopaminergic system

Effects of zonisamide (ZNS) on extracellular dopamine (DA), its precursor 3,4-dihydroxyphenylalanine (DOPA), its metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) levels in the striatum as well as hippocampus of freely moving rats were studied. Intracellular DA, DOPA, DOPAC and HVA levels, as well as DOPA accumulation as an index of tyrosine hydroxylase activity in the rat brain in vivo, DA re-uptake in the striatum and hippocampus, and monoamine oxidase (MAO) activities were also determined. Acute administrations of therapeutic ZNS doses (20 and 50 mg/kg) increased striatal extracellular DOPA levels, intracellular striatal and hippocampal DOPA levels, and stimulated DOPA accumulation in both brain regions. ZNS also increased striatal and hippocampal intracellular as well as extracellular DA and MIA Levels, but decreased those of DOPAC levels. Chronic (3 weeks) administrations of therapeutic ZNS doses (20 and 50 mg/kg/day) increased intracellular DA, DOPA, DOPAC and HVA levels in striatum and hippocampus. ZNS-induced changes were greater in intracellular levels than in extracellular levels. Acute and chronic supratherapeutic ZNS dose (100 mg/kg) administration decreased intracellular levels of all substances detectable in both brain regions, and inhibited DOPA accumulation. Both subtypes of MAO (type A and type B) activities were weakly inhibited by ZNS. ZNS showed no effect on DA re-uptake in striatum nor in hippocampus. These results suggest that therapeutic ZNS doses increase DOPA accumulation as well as both intracellular and extracellular DA, DOPA and HVA levels. However, such doses also decrease extracellular and intracellular DOPAC levels by enhancing DA synthesis and/or by selectively inhibiting MAO-B activities. In addition, chronic therapeutic ZNS dose administration enhances DA synthesis, which results in increased intracellular DA, its precursor and its metabolites levels. On the other hand, both acute and chronic supratherapeutic ZNS dose administrations inhibit DA turnover. These ZNS effects on DA metabolism are at least partly involved in the mechanisms of action of ZNS.

Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 99-06-9, Category: Benzisoxazole.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Related Products of 75-98-9, Children learn through play, and they learn more than adults might expect. Science experiments are a great way to spark their curiosity, 75-98-9, Name is Pivalic acid, SMILES is CC(C)(C)C(O)=O, belongs to Benzisoxazole compound. In a article, author is Seino, M, introduce new discover of the category.

Review of zonisamide development in Japan

Zonisamide is a benzisoxazole-based compound first synthesized in the early 1970s by the research laboratories of Dainippon Pharmaceutical Company in Osaka, Japan. Identified as an anticonvulsant during exploratory research, zonisamide has since been characterized as having broad-spectrum antiepitepsy and neuroprotective effects. Early clinical studies in Japan demonstrated that zonisamide has a long elimination half-life and is well tolerated; Phase II and III clinical trials established the drug’s efficacy and safety for the treatment of partial and generalized seizures. In 1989, zonisamide was approved and marketed in Japan under the trade name of Excegran(R). Data from postmarketing surveillance studies and clinical observations over 10 years of use have continued to support zonisamide’s efficacy and safety, identified its usefulness as monotherapy, and characterized its effectiveness for various seizure types and epilepsy syndromes. (C) 2004 Published by Elsevier Ltd on behalf of BEA Trading Ltd.

Related Products of 75-98-9, One of the oldest and most widely used commercial enzyme inhibitors is aspirin, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 75-98-9.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Chemistry is the experimental and theoretical study of materials on their properties at both the macroscopic and microscopic levels. 526-83-0, Name is 2,3-Dihydroxysuccinic acid, molecular formula is C4H6O6. In an article, author is GARCIA, G,once mentioned of 526-83-0, Recommanded Product: 2,3-Dihydroxysuccinic acid.

RISPERIDONE – AN ATYPICAL AGENT APPROVED AS 1ST-LINE THERAPY FOR MANAGING MANIFESTATIONS OF PSYCHOTIC DISORDERS

Risperidone, a benzisoxazole derivative, was recently approved by the FDA for the management of psychotic disorders. It joins clozapine as the second antipsychotic agent to become available that possesses both dopaminergic and serotoninergic blocking activities. Risperidone has been shown to improve the positive and negative symptoms of schizophrenia in clinical trials. The drug can be used as a first-line agent and trials are currently being conducted to establish its benefit in treatment-refractory patients. Risperidone is associated with a low incidence of extrapyramidal symptoms, has not been associated with tardive dyskinesia, and does not require hematological monitoring. The availability of risperidone represents progress not only in the pharmacotherapy of schizophrenia, but also in the understanding of the pathophysiology of this disorder.

Interested yet? Keep reading other articles of 526-83-0, you can contact me at any time and look forward to more communication. Recommanded Product: 2,3-Dihydroxysuccinic acid.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics

Chemistry is the science of change. But why do chemical reactions take place? Why do chemicals react with each other? The answer is in thermodynamics and kinetics, Application In Synthesis of 3-(Methoxycarbonyl)bicyclo[1.1.1]pentane-1-carboxylic acid, 83249-10-9, Name is 3-(Methoxycarbonyl)bicyclo[1.1.1]pentane-1-carboxylic acid, SMILES is O=C(C1(C2)CC2(C(OC)=O)C1)O, belongs to Benzisoxazole compound. In a document, author is GARCIA, G, introduce the new discover.

RISPERIDONE – AN ATYPICAL AGENT APPROVED AS 1ST-LINE THERAPY FOR MANAGING MANIFESTATIONS OF PSYCHOTIC DISORDERS

Risperidone, a benzisoxazole derivative, was recently approved by the FDA for the management of psychotic disorders. It joins clozapine as the second antipsychotic agent to become available that possesses both dopaminergic and serotoninergic blocking activities. Risperidone has been shown to improve the positive and negative symptoms of schizophrenia in clinical trials. The drug can be used as a first-line agent and trials are currently being conducted to establish its benefit in treatment-refractory patients. Risperidone is associated with a low incidence of extrapyramidal symptoms, has not been associated with tardive dyskinesia, and does not require hematological monitoring. The availability of risperidone represents progress not only in the pharmacotherapy of schizophrenia, but also in the understanding of the pathophysiology of this disorder.

The proportionality constant is the rate constant for the particular unimolecular reaction. the reaction rate is directly proportional to the concentration of the reactant. I hope my blog about 83249-10-9 is helpful to your research. Application In Synthesis of 3-(Methoxycarbonyl)bicyclo[1.1.1]pentane-1-carboxylic acid.

Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics